• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Treatment of surgically induced acute liver failure with transplantation of highly differentiated immortalized human hepatocytes.

作者信息

Kobayashi N, Miyazaki M, Fukaya K, Inoue Y, Sakaguchi M, Noguchi H, Matsumura T, Watanabe T, Totsugawa T, Tanaka N, Namba M

机构信息

Department of Cell Biology, Institute of Molecular and Cellular Biology, Okayama University Medical School, Japan.

出版信息

Cell Transplant. 2000 Sep-Oct;9(5):733-5. doi: 10.1177/096368970000900524.

DOI:10.1177/096368970000900524
PMID:11144975
Abstract

Primary human hepatocytes are an ideal source of hepatic function in bioartficial liver (BAL), but the shortage of human livers available for hepatocyte isolation limits this modality. To resolve this issue, primary human fetal hepatocytes were immortalized using simian virus 40 large T antigen. One of the immortal cell lines, OUMS-29, showed highly differentiated liver functions. Intrasplenic transplantation of OUMS-29 cells protected 90% hepatectomized rats from hyperammonemia and significantly prolonged their survival. Essentially unlimited availability of OUMS-29 cells supports their clinical use for BAL treatment.

摘要

相似文献

1
Treatment of surgically induced acute liver failure with transplantation of highly differentiated immortalized human hepatocytes.
Cell Transplant. 2000 Sep-Oct;9(5):733-5. doi: 10.1177/096368970000900524.
2
Transplantation of highly differentiated immortalized human hepatocytes to treat acute liver failure.
Transplantation. 2000 Jan 27;69(2):202-7. doi: 10.1097/00007890-200001270-00002.
3
Transplantation of immortalized human fetal hepatocytes prevents acute liver failure in 90% hepatectomized mice.永生化人胎儿肝细胞移植可预防90%肝切除小鼠的急性肝衰竭。
Transplant Proc. 2010 Jun;42(5):1907-14. doi: 10.1016/j.transproceed.2010.01.061.
4
Treatment of surgically induced acute liver failure by transplantation of conditionally immortalized hepatocytes.
Transplantation. 1997 Jun 15;63(11):1541-7. doi: 10.1097/00007890-199706150-00001.
5
Intrasplenic transplantation of immortalized human fetal hepatocytes prolongs the survival of 90% hepatectomized rats.永生化人胎儿肝细胞脾内移植可延长90%肝切除大鼠的生存期。
Transplant Proc. 2000 Nov;32(7):2365-7. doi: 10.1016/s0041-1345(00)01701-2.
6
Establishment of highly differentiated immortalized human hepatocyte line with simian virus 40 large tumor antigen for liver based cell therapy.利用猿猴病毒40大肿瘤抗原建立高度分化的永生化人肝细胞系用于肝脏细胞治疗
ASAIO J. 2005 May-Jun;51(3):262-8. doi: 10.1097/01.mat.0000161045.16805.8b.
7
Expansion of human hepatocyte populations by a retroviral gene transfer of simian virus 40 large T antigen.
ASAIO J. 2001 Sep-Oct;47(5):481-5. doi: 10.1097/00002480-200109000-00017.
8
Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes.用永生化肝细胞移植治疗终末期肝硬化大鼠的肝衰竭
Hepatology. 2002 Aug;36(2):386-94. doi: 10.1053/jhep.2002.34614.
9
Establishment and characterization of immortalized porcine hepatocytes for the study of hepatocyte xenotransplantation.用于肝细胞异种移植研究的永生化猪肝细胞的建立与特性分析
Transplant Proc. 2010 Jun;42(5):1899-906. doi: 10.1016/j.transproceed.2009.11.043.
10
Immortalization of hepatic progenitor cells.肝祖细胞的永生化
Pathol Biol (Paris). 2004 Mar;52(2):93-6. doi: 10.1016/j.patbio.2003.02.001.

引用本文的文献

1
Hepatocyte nuclear factor 4α is a critical factor for the production of complement components in the liver.肝细胞核因子4α是肝脏中补体成分产生的关键因子。
In Vitro Cell Dev Biol Anim. 2024 Dec;60(10):1174-1183. doi: 10.1007/s11626-024-00972-6. Epub 2024 Sep 16.
2
Practical Use of Immortalized Cells in Medicine: Current Advances and Future Perspectives.医学中永生细胞的实际应用:当前进展和未来展望。
Int J Mol Sci. 2023 Aug 12;24(16):12716. doi: 10.3390/ijms241612716.
3
Expansion of functional personalized cells with specific transgene combinations.
通过特定转基因组合对功能性个性化细胞进行扩增。
Nat Commun. 2018 Mar 8;9(1):994. doi: 10.1038/s41467-018-03408-4.
4
Cellular Transplantation for Liver Diseases.用于肝脏疾病的细胞移植
Gastroenterology Res. 2008 Dec;1(1):8-13. doi: 10.4021/gr2008.11.1243. Epub 2008 Nov 20.
5
Review of the history and current status of cell-transplant approaches for the management of neuropathic pain.用于治疗神经性疼痛的细胞移植方法的历史与现状综述。
Pain Res Treat. 2012;2012:263972. doi: 10.1155/2012/263972. Epub 2012 Jun 14.
6
Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells.色素上皮衍生因子抑制 HepG2 细胞中 Bcl-xL 的溶酶体降解和细胞凋亡。
Am J Pathol. 2010 Jan;176(1):168-76. doi: 10.2353/ajpath.2010.090242. Epub 2009 Nov 30.
7
The possible use of stem cells in regenerative medicine: dream or reality?干细胞在再生医学中的可能应用:梦想还是现实?
Langenbecks Arch Surg. 2009 Nov;394(6):985-97. doi: 10.1007/s00423-009-0546-0. Epub 2009 Jul 31.
8
Hepatitis B virus X protein overcomes oncogenic RAS-induced senescence in human immortalized cells.乙型肝炎病毒X蛋白可克服致癌性RAS诱导的人永生化细胞衰老。
Cancer Sci. 2007 Oct;98(10):1540-8. doi: 10.1111/j.1349-7006.2007.00579.x.
9
Construction of IL-2 gene-modified human hepatocyte and its cultivation with microcarrier.白细胞介素-2基因修饰人肝细胞的构建及其与微载体的培养
World J Gastroenterol. 2003 Jan;9(1):79-83. doi: 10.3748/wjg.v9.i1.79.